Your Feed

Filter by
See content from
Back to the latest
Avatar
Donna
Multiple Myeloma Discussion • June 29
Post car t bloodwork
Five weeks after car t I had my bloodwork done. My kappa came back as . 6 Lambda was 3.24 ( not sure it was 3 something) I’m kappa so I care more about that. Ratio not calculated since the values were so low. I’m thinking this is a good sign that the car t is working. Anyone else hade these results or your thoughts please
Thumbnail for Beyond IMiDs: Cemsidomide — A Next-Generation Cereblon Degrader Shows Promise in Myeloma | EHA 2026
Playlist: EHA 2026

Beyond IMiDs: Cemsidomide — A Next-Generation Cereblon Degrader Shows Promise in Myeloma | EHA 2026

Video details & playlist
Thumbnail for Talquetamab Steps Forward: MonumenTAL-3 - A New Potential for GPRC5D Therapy in Myeloma | EHA 2026
Playlist: EHA 2026

Talquetamab Steps Forward: MonumenTAL-3 - A New Potential for GPRC5D Therapy in Myeloma | EHA 2026

Video details & playlist
Thumbnail for CAR-T Without the Wait: Reprogramming T-cells Inside Your Body for Myeloma | EHA 2026
Playlist: EHA 2026

CAR-T Without the Wait: Reprogramming T-cells Inside Your Body for Myeloma | EHA 2026

Video details & playlist
Thumbnail for Next Generation of CAR-T: AZD0120 Dual BCMA/CD19 CAR-T w/ Rapid Manufacturing for Myeloma | EHA 2026
Playlist: EHA 2026

Next Generation of CAR-T: AZD0120 Dual BCMA/CD19 CAR-T w/ Rapid Manufacturing for Myeloma | EHA 2026

Video details & playlist
Thumbnail for Next Generation of CAR-T: AZD0120 Dual BCMA/CD19 CAR-T w/ Rapid Manufacturing for Myeloma | EHA 2026
Playlist: EHA 2026

Next Generation of CAR-T: AZD0120 Dual BCMA/CD19 CAR-T w/ Rapid Manufacturing for Myeloma | EHA 2026

Video details & playlist
Thumbnail for Beyond MRD Negative: FORTE Trial Reveals Why Staying MRD Negative Matters in Myeloma | ASCO 2026
Playlist: EHA 2026

Beyond MRD Negative: FORTE Trial Reveals Why Staying MRD Negative Matters in Myeloma | ASCO 2026

Video details & playlist
Thumbnail for Duffy Null & High-Risk Myeloma in Black Patients: Insights from CoMMpass & HORIZON Study | EHA 2026
Playlist: EHA 2026

Duffy Null & High-Risk Myeloma in Black Patients: Insights from CoMMpass & HORIZON Study | EHA 2026

Video details & playlist
Avatar
Pheba1
Multiple Myeloma Discussion • June 27
What causes MM?
On Wednesday of last week I attended a birthday party for a friend in my sewing group. She just turned 90. I baked the cake. My first layer cake in decades, a carrot cake. It turned out great. After food and cake we sat around the table chatting. They know I have MM. Then they went around the table in a circle talking about family members, and friends they know with MM. There were 7 ladies and 7 family members or friends with MM. I was floored. Why so many? I saw my oncologist on Thursday. I told him about the party. He said MM was endemic in our area. I asked him what caused it. He said cancer is caused by 3 things; what we do to our self, what the environment does to us, and what we inherit from our ancestors. That was as clear as an answer as I could get. I am guessing that the truth is that doctors and scientist suspect what causes some cancers, but have no proof. I do know I live in a rural area with farming and pesticides. The neighbor behind us died two years ago from Leukemia. Another neighbor died two years ago from Leukemia also. I suspect it may be more complicated. We have something called epi-genes, genes that turn genes on or off. Some people have epi-genes that can mutate a chromosome when exposed to a cancer causing agent. Others have epi-genes that do not get turned on, even if they take a bath in a pesticide. We may never know, but I find the coincidence of MM being endemic in our area interesting.
Thumbnail for Is Autologous Stem Cell Transplant Still Standard of Care in Myeloma? New Data from EHA 2026
Playlist: EHA 2026

Is Autologous Stem Cell Transplant Still Standard of Care in Myeloma? New Data from EHA 2026

Video details & playlist
Thumbnail for Arlocabtagene Autoleucel (Arlo-Cel): Promising GPRC5D CAR-T Results in Relapsed Myeloma | EHA 2026
Playlist: EHA 2026

Arlocabtagene Autoleucel (Arlo-Cel): Promising GPRC5D CAR-T Results in Relapsed Myeloma | EHA 2026

Video details & playlist
Thumbnail for CAR-T vs Bispecifics — Which Performs Better in Myeloma After Initial BCMA Therapy Fails? | #EHA2026
Playlist: EHA 2026

CAR-T vs Bispecifics — Which Performs Better in Myeloma After Initial BCMA Therapy Fails? | #EHA2026

Video details & playlist
Thumbnail for A New Way to Deliver Isatuximab in Myeloma: Safety Insights on the On-Body Injector (OBI) | #EHA2026
Playlist: EHA 2026

A New Way to Deliver Isatuximab in Myeloma: Safety Insights on the On-Body Injector (OBI) | #EHA2026

Video details & playlist
Thumbnail for BMS-986453 : A Next-Generation Dual-Target CAR-T Attacking BCMA + GPRC5D in  Myeloma | #EHA2026
Playlist: EHA 2026

BMS-986453 : A Next-Generation Dual-Target CAR-T Attacking BCMA + GPRC5D in Myeloma | #EHA2026

Video details & playlist
Thumbnail for MajesTEC-4 / EMN30 Trial: Is Teclistamab the Future of Myeloma Maintenance After Transplant? | EHA26
Playlist: EHA 2026

MajesTEC-4 / EMN30 Trial: Is Teclistamab the Future of Myeloma Maintenance After Transplant? | EHA26

Video details & playlist